SU2C-SARC032: A phase II randomized controlled trial of neoadjuvant pembrolizumab with radiotherapy and adjuvant pembrolizumab for high-risk soft tissue sarcoma.
暂无分享,去创建一个
B. Brigman | M. Burgess | D. Reinke | R. Riedel | D. Kirsch | C. Meyer | S. Schuetze | K. Ballman | M. Milhem | B. Chmielowski | S. Attia | Y. Mowery | B. A. Tine | G. Tinoco | M. Dickson | L. Hartner | A. Wagner